 Our study found that the COVID-19 pandemic has had a significant impact on the amount of time antimicrobial stewardship pharmacists spend on non-clinical tasks such as pre-authorizations and administrative meetings. This shift away from clinical activities could lead to decreases in antimicrobial use, which could have implications for patient safety. This article was authored by Megan R. Wimmer, Lucas T. Schultz, Ashley G. Hamel and others.